MLYS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -1.147, suggesting MLYS is Strong Sell.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 26.628, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 27.333, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it Sell.

Technical Analysis for MLYS

Technical Sentiment Analysis for Mineralys Therapeutics Inc (MLYS) As of 2026-06-18, Mineralys Therapeutics Inc (MLYS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 9 technical signals, shows that 2 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for MLYS stands at 42.847, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -1.147, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 23.385 and the Commodity Channel Index (CCI) at -36.605 further confirm a -0.42 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, MLYS is trading below its 60-day moving average of $27.333 and below its 200-day long-term moving average of $33.093. Key price levels to watch include the immediate resistance at $25.851 and strong support at $22.161. A break above $25.851 could signal a bull continuation, while falling below $22.161 may test the next Fibonacci floor at $20.385.

Mineralys Therapeutics Inc (MLYS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	18.471	20.385	22.161	24.075	25.851	27.765	29.541
Fibonacci	20.385	21.795	22.666	24.075	25.485	26.356	27.765

Mineralys Therapeutics Inc (MLYS) Technical Indicators

2026-06-18

Name	Value
RSI_14	42.847
STOCHk_14_3_3	23.385
STOCHd_14_3_3	19.956
CCI_20	-36.605
AO_5_34	-3.049
MOM_10	-0.42
MACD_12_26_9	-1.147

Mineralys Therapeutics Inc (MLYS) Relative Strength Index (RSI) is 42.847, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic Oscillator is 23.385, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic RSI is 19.956, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Commodity Channel Index (CCI) is -36.605, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Awesome Oscillator is -3.049, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Momentum is -0.42, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) MACD is -1.147, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Moving Average

2026-06-18

Period	Simple	Signal
MA_5	24.258	Buy
MA_10	23.936	Buy
MA_20	26.628	Sell
MA_60	27.333	Sell
MA_200	33.093	Sell
MA_250	29.363	Sell

Mineralys Therapeutics Inc (MLYS) 5-Day simple moving average is 24.258, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 10-Day simple moving average is 23.936, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 26.628, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 27.333, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 200-Day simple moving average is 33.093, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 250-Day simple moving average is 29.363, while Mineralys Therapeutics Inc (MLYS) share price is $24.63, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for MLYS?

The overall technical consensus for Mineralys Therapeutics Inc (MLYS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 0 buy signals and 3 sell signals.

What are the key support and resistance levels for Mineralys Therapeutics Inc (MLYS) today?

Based on pivot point calculations, Mineralys Therapeutics Inc (MLYS) has an immediate support level at 22.161 and a major resistance level at 25.851. Traders also monitor the pivot point at 24.075 to determine the intraday trend direction.

Is Mineralys Therapeutics Inc (MLYS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Mineralys Therapeutics Inc (MLYS) is currently 42.847. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Mineralys Therapeutics Inc (MLYS)?

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -1.147, suggesting MLYS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Mineralys Therapeutics Inc.

How is Mineralys Therapeutics Inc (MLYS) performing relative to its 200-day moving average?

Mineralys Therapeutics Inc (MLYS) is currently trading at $24.63, which is below its 200-day simple moving average of 33.093. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.